Evidence map›Paper›PMID 27744012›Full record

Trial reportBone2017

Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Pamela S Hinton, Peggy Nigh, John Thyfault

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Bone, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Trial
  4. Trial
  5. Review
  6. Exercise and Musculoskeletal Health in Men With Low Bone Mineral Density: A Systematic Review.Archives of rehabilitation research and clinical translation · 2024
    Review
  7. Article
  8. Review
  9. Evidence in Humans for Bone as an Endocrine Organ Regulating Energy Metabolism.Current opinion in endocrine and metabolic research · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Effects of Six-Week Resistance Training with or without Vibration on Metabolic Markers of Bone Metabolism.International journal of environmental research and public health · 2021
    Article
  14. Article
  15. Review
  16. Romosozumab: a novel bone anabolic treatment option for osteoporosis?Wiener medizinische Wochenschrift (1946) · 2020
    Article
  17. Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pamela S HintonDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, United States. Electronic address: hintonp@missouri.edu.
Peggy NighDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, United States.
John ThyfaultDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, United States; Internal Medicine - Division of GI and Hepatology, University of Missouri, Columbia, MO 65211, United States.
University of Missouri · US

Funding

Aerobic fitness, mitochondrial dysfunction, and fatty liver diseaseR01DK088940 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI THYFAULT, JOHN P · 2011 to 2015
$1.5M
Efficacy of Plyometrics to Increase Bone Mass in MenR03AR055738 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI HINTON, PAMELA S · 2009 to 2011
$211k
NIAMS NIH HHS R03 AR055738NIDDK NIH HHS R01 DK088940
6 · The paper itself

Abstract

purposeWe previously reported that 12months of resistance training (RT, 2×/wk, N=19) or jump training (JUMP, 3×/wk, N=19) increased whole body and lumbar spine BMD and increased serum bone formation markers relative to resorption in physically active (≥4h/wk) men (mean age: 44±2y; median: 44y) with osteopenia of the hip or spine. The purpose of this secondary analysis was to examine the effects of the RT or JUMP intervention on potential endocrine mediators of the exercise effects on bone, specifically IGF-I, PTH and sclerostin.

methodsFasting blood samples were collected after a 24-h period of no exercise at baseline and after 12months of RT or JUMP. IGF-I, PTH and sclerostin were measured in serum by ELISA. The effects of RT or JUMP on IGF-I, PTH and sclerostin were evaluated using 2×2 repeated measures ANOVA (time, group). This study was conducted in accordance with the Declaration of Helsinki and was approved by the University of Missouri IRB.

resultsSclerostin concentrations in serum significantly decreased and IGF-I significantly increased after 12months of RT or JUMP; while PTH remained unchanged.

conclusionThe beneficial effects of long-term, progressive-intensity RT or JUMP on BMD in moderately active men with low bone mass are associated with decreased sclerostin and increased IGF-I.

Indexed as

LocomotionResistance TrainingAdaptor Proteins, Signal TransducingAdultBone and BonesBone DensityBone Morphogenetic ProteinsGenetic MarkersHumansInsulin-Like Growth Factor IMaleMiddle AgedOrgan SizeParathyroid HormoneAdaptor Proteins, Signal TransducingBone Morphogenetic ProteinsGenetic MarkersInsulin-Like Growth Factor IParathyroid HormoneSOST protein, humanExercise interventionIGF-IMale osteopeniaPTHSclerostin

Identifiers

PMID27744012
PMCPMC5328803
OpenAlexW2530869290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.